P.S. Free 2026 Salesforce ALS-Con-201 dumps are available on Google Drive shared by PDFDumps: https://drive.google.com/open?id=1OSr8yK_LlX431KGrRFwJfot2arxM_kTX
The accuracy rate of ALS-Con-201 test training materials of PDFDumps is high with wide coverage. It will be the most suitable ALS-Con-201 test training materials and the one you need most to pass ALS-Con-201 exam. We promise that we will provide renewal service freely as long as one year after you purchase our ALS-Con-201 Dumps; if you fail ALS-Con-201 test or there are any quality problem of our ALS-Con-201 exam dumps and training materials, we will give a full refund immediately.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
>> New ALS-Con-201 Study Plan <<
Our ALS-Con-201 exam materials are compiled by experts and approved by the professionals who are experienced. They are revised and updated according to the pass exam papers and the popular trend in the industry. The language of our ALS-Con-201 exam torrent is simple to be understood and our ALS-Con-201 test questions are suitable for any learners. The content of our ALS-Con-201 Study Materials is easy to be mastered and has simplified the important information. Our ALS-Con-201 test questions convey the latest and valid questions and answers and thus make the learning relaxing and efficient.
NEW QUESTION # 66
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement Sprints to manage two-week execution cycles. Key Account Managers (KAMs) are marking their sprints as "Finished" in the picklist, but the system does not recognize them as closed for reporting purposes. The picklist value must map to the system state.
Where should the Agentforce Life Sciences Consultant configure this mapping?
Answer: C
Explanation:
The correct answer is B because sprint completion values are configured in the Life Sciences Admin Console under Key Account Management sprint settings. Salesforce Help for Configure Sprint Completion Statuses states that administrators should go to the App Launcher, open Admin Console, select Key Account Management, and then select Sprints Settings in the left navigation pane. From there, admins add the sprint values that indicate completion.
The scenario says KAMs are selecting a picklist value called "Finished," but the system does not recognize the sprint as closed for reporting. That means the label exists as a picklist option, but it has not been mapped as a completion status in the Life Sciences Key Account Management sprint configuration. The consultant must configure the completion-status mapping in Sprint Settings so the platform treats "Finished" as a closed/completed sprint value.
Option A is too broad and does not point to the specific sprint completion configuration. Option C is also incorrect because editing the Status picklist in Object Manager only changes or adds picklist values. It does not tell the Life Sciences Key Account Management logic which values count as completed for reporting and process behavior. Therefore, the mapping should be configured in Admin Console > Key Account Management > Sprint Settings.
=========
NEW QUESTION # 67
Choose 1 option.
Cumulus Pharma enforces Chain of Custody protocols for its restricted product, Immunexis. During an in-person field visit, a field sales rep physically hands over five sample packs to a Healthcare Provider (HCP). To adhere to regulatory compliance and generate the required electronic receipt for this transaction, the rep must finalize the disbursement record in the Agentforce Life Sciences mobile app.
Which required action must the rep take to complete this physical custody transfer?
Answer: A
Explanation:
The correct answer is B because physical sample disbursement to an HCP requires compliant signature capture to confirm the handoff and support the audit trail. Salesforce's Life Sciences Customer Engagement data model states that Provider Visit Management supports compliance requirements for sample eligibility, sample limits, allocations, and e-signature capture. Salesforce also describes Electronic Signatures through Digital Verifications as the way to set up signature trails for records or workflows that require users to verify key updates.
In this scenario, the field sales rep is physically transferring custody of a restricted product to the HCP. To finalize that disbursement and generate the required electronic receipt, the rep must capture the HCP's digital signature directly on the mobile device. This ties the transaction to the HCP, the product, the quantity, the timestamp, and the specific disbursement event.
Option A is incorrect because an Inventory Adjustment is used to reconcile inventory discrepancies or administrative stock changes, not to document a compliant HCP sample handoff. Option C is also incorrect because a confirmation email is not the standard Life Sciences sample-disbursement action for chain-of-custody compliance. The required mobile action is direct digital signature capture from the HCP.
=========
NEW QUESTION # 68
Choose 1 option.
An Agentforce Life Sciences Consultant wants to identify whether a physician is flagged as a speaker.
Which object contains this information in Agentforce Life Sciences for Customer Engagement?
Answer: B
Explanation:
Option B is correct because the Healthcare Provider object contains provider-specific Life Sciences attributes, including whether the provider is designated as a speaker for engagement. Salesforce's Life Sciences Cloud Developer Guide for the HealthcareProvider object states that the object and its fields are used by Account Management and Segmentation, and the search result for the same Salesforce object documentation identifies a field that indicates whether the provider is designated as a speaker for engagement, with a default value of false. This directly matches the question's requirement to identify whether a physician is flagged as a speaker.
Option A, Board Certification, is incorrect because board certification stores credential or certification information about a provider. It may help qualify the provider professionally, but it does not represent the commercial engagement flag that identifies whether the provider is a speaker. Option C, Person Account, is also not the best answer. In Life Sciences Cloud, physicians are commonly represented through Person Accounts, but the speaker designation is stored in the Healthcare Provider data model, not as a generic Person Account-only attribute.
Therefore, when the consultant needs to identify whether a physician is flagged as a speaker in Agentforce Life Sciences for Customer Engagement, the correct object to reference is Healthcare Provider.
=========
NEW QUESTION # 69
Choose 1 option.
Cumulus Pharma has a compliance policy regarding "Off-Label" discussions. The company's Agentforce Life Sciences Consultant needs to configure the Agentforce Life Sciences visit experience to explicitly control whether field sales reps are allowed to discuss products for indications that have not yet been approved.
Which setting within the Admin Console handles this capability?
Answer: A
Explanation:
The correct answer is B because off-label control in the visit experience is tied to product detailing behavior. In life sciences commercial engagement, product detailing governs what products, messages, indications, and approved content can be discussed or shown during a visit. Salesforce Trailhead describes Life Sciences Cloud content visibility as being filtered by territory, product assignment, and account restrictions to prevent off-label or noncompliant sharing. This aligns most closely with Visit Settings > Product Detailing Settings, because that is the visit configuration area where product discussion and detailing behavior is controlled.
The question asks where the consultant should configure whether reps are allowed to discuss products for unapproved indications. That is not a generic compliance switch; it is a visit-detailing control connected to product and indication behavior in the field engagement workflow. Product Detailing Settings are therefore the correct place to enforce whether off-label discussion is permitted, warned, or restricted according to company policy.
Option A is incorrect because "Compliance Settings > Off-Label Validation" is not the standard configuration path presented in the available options for the Life Sciences visit experience. Option C is also incorrect because Restricted Products would control whether products are available or restricted, but the scenario is specifically about discussion of unapproved indications during product detailing. Therefore, the consultant should use Visit Settings > Product Detailing Settings.
=========
NEW QUESTION # 70
Choose 1 option.
An Agentforce Life Sciences Consultant is asked to configure strategic distribution limits for Immunexis 50mg in a high-growth territory. The business requirement mandates that the total quantity available for the territory in the next quarter is capped, and individual field sales reps are restricted from handing off more than 50 units in a single visit.
Which administrative configuration should the consultant recommend?
Answer: A
Explanation:
Option C is correct because Territory Product Quantity Allocations are designed to manage sample product distribution at the territory level. Salesforce Help explains that territory product quantity allocations and sample limits both help manage sample distribution to HCPs, but territory product quantity allocation is used when the business needs to allocate a defined product quantity to a territory. Salesforce's setup guidance for Territory Product Quantity Allocations also states that Max Disbursement Limit Quantity is the maximum amount a sales rep can disburse in a given visit.
This directly matches the requirement. Cumulus Pharma wants to cap the total quantity of Immunexis 50mg available for a high-growth territory in the next quarter and also prevent reps from handing off more than 50 units in a single visit. A Territory Product Quantity Allocation record can store the territory-level allocated quantity, while Max Disbursement Limit Quantity enforces the per-visit disbursement cap.
Option A is incorrect because an Advanced Sample Limit Template focuses on account or provider-level sample limits, not the total allocation available to a territory. Option B is also incorrect because changing the Life Sciences Marketable Product globally would affect the entire organization, not just the high-growth territory. Therefore, the correct recommendation is to create a Territory Product Quantity Allocation record and set the per-visit max disbursement limit to 50.
=========
NEW QUESTION # 71
......
As the saying goes, practice makes perfect. We are now engaged in the pursuit of Craftsman spirit in all walks of life. Professional and mature talents are needed in each field, similarly, only high-quality and high-precision Salesforce Certified Agentforce Life Sciences Consultant qualification question can enable learners to be confident to take the qualification examination so that they can get the certificate successfully, and our ALS-Con-201 Learning Materials are such high-quality learning materials, it can meet the user to learn the most popular test site knowledge. Because our experts have extracted the frequent annual test centers are summarized to provide users with reference.
ALS-Con-201 Exam Guide Materials: https://www.pdfdumps.com/ALS-Con-201-valid-exam.html
P.S. Free 2026 Salesforce ALS-Con-201 dumps are available on Google Drive shared by PDFDumps: https://drive.google.com/open?id=1OSr8yK_LlX431KGrRFwJfot2arxM_kTX